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Abstract 
MCT14 is an orphan transporter belonging to the SLC16 transporter family mediating 
the transport of monocarboxylates, aromatic amino acids, creatine, and thyroid 
hormones. The expression, tissue localization, regulation, and function of MCT14 are 
unknown. In mouse MCT14 mRNA abundance is highest in kidney. Using a newly 
developed and validated antibody, MCT14 was localized to the luminal membrane of 
the thick ascending limb of the loop of Henle colocalizing in the same cells with 
uromodulin and NKCC2. MCT14 mRNA and protein was found to be highly regulated 
by dietary phosphate intake in mice being increased by high dietary phosphate intake 
at both mRNA and protein level. In order to identify the transport substrate(s), we 
expressed MCT14 in Xenopus laevis oocytes where MCT14 was integrated into the 
plasma membrane. However, no transport was discovered for the classic substrates 
of the SLC16 family nor for phosphate. In summary, MCT14 is an orphan transporter 
regulated by phosphate and highly enriched in kidney localizing to the luminal 
membrane of one specific nephron segment. 
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Introduction 
Inorganic phosphate is a molecule involved in energy metabolism and signaling as 
well as essential for structural molecules in cells and bone. Phosphate excess 
triggers ectopic calcifications and is associated with increased cardiovascular 
mortality. Therefore, the plasma levels of phosphate are kept in a close range; this is 
achieved by a variety of compensatory and highly regulated mechanisms. Phosphate 
deficiency leads to increased levels of plasma active vitamin D, which promotes 
intestinal phosphate absorption at least in part by stimulating the expression of the 
Na+-dependent phosphate transporter NaPi-IIb [1]. Additionally, hypophosphatemia 
blunts the production of parathyroid hormone (PTH) [2]  and fibroblast growth factor 
23 (FGF23) [3], releasing the inhibitory effect of both hormones on renal phosphate 
cotransporters (NaPi-IIa, NaPi-IIc and PiT-2), thus enhancing renal reabsorption of 
phosphate. On the other hand hyperphosphatemia leads to an increased renal 
excretion of phosphate, an effect mediated at least in part by PTH [2]  and FGF23 [4-
6] . Both hormones reduce the renal expression of NaPi-IIa NaPi-IIc and PiT-2 in the 
proximal tubule [2], and FGF23 additionally suppresses the production of vitamin 
D[7]. But beyond these effects directly linked to phosphate metabolism, alterations in 
phosphate intake affect, among other effects, glycogenolysis and glucose production 
[8], indicating broader systemic changes in response to phosphate status.  
The SLC16 gene family comprises 14 members collectively called MCTs 
(monocarboxylate transporter) due to the fact that the first 4 members to be 
characterized mediate transport of monocarboxylates such as lactate, pyruvate and 
ketone bodies, in a proton dependent manner [9]. MCT1, 3 and 4 associate with 
CD147 (basigin) [10], an immunoglobulin-like protein, that acts as a chaperone for 
these MCTs. The interaction of MCT1 and CD147 has been extensively studied and 
it was shown that sorting of MCT1 to the right pole of an epithelial cell relies on 
CD147 [11]. MCT1 and 2 are both expressed in kidney where they are involved in 
reabsorbing lactate. MCT1 is localized to the basolateral membrane of the renal 
proximal tubule together with CD147 [12], whereas MCT2 is found in the basolateral 
membrane of cells in the thick ascending limb of the loop of Henle [13]. 
The characterization of further members of the SLC16 family revealed that transport 
by MCTs is not limited to monocarboxylates. MCT8 transports thyroid hormone [14] 
and mutations of MCT8 associate with elevated levels of triiodothyronine (T3) and 
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psychomotor retardation [15]. MCT10 is an aromatic amino acid transporter, also 
known as TAT1 (T-type amino acid transporter 1). Both transporters mediate 
transport in a proton (and sodium) independent manner [16], unlike the first 4 
members. Recently MCT12, associated with juvenile cataract, was characterized as 
a creatine transporter [17], further widening the substrate spectrum of the MCT 
family. MCT12 localizes to the basolateral membrane of proximal tubules in kidney, 
and patients with mutated MCT12 excrete increased amounts of guanidinoacetate, 
but functional studies did not show transport of the creatine precursor [18]. The other 
members of the family remain orphan transporters, and although it has been 
suggested that they might act as drug transporters (as demonstrated with 
bumetanide transport for MCT6 [19]) their endogenous transport substrates are still 
elusive. A renal transcriptome study detected mRNA of MCT1, MCT2, MCT5, MCT6, 
MCT7, MCT8, MCT9, MCT10 (TAT1), MCT13 and MCT14 in kidney [20], and the 
renal localization of MCT1, 2, 7, 8 and 10 has been described [12,21].   
MCT14, encoded by the SLC16A14 gene, is an orphan member of the family that has 
been shown to be expressed in the bovine intestinal tract [22] and the mammary 
gland of lactating cows [23]. A recent study also mapped the expression of MCT14 in 
the mouse brain and provided a relative expression of this transporter in several 
tissues [24]. Of interest, among all the tissues tested renal mRNA abundance was 
the highest (by about 20 fold). This report also provides a phylogenetic analysis of 
the MCTs, which shows that MCT14 is closest related to MCT8, 9 and 10 [24], the 
non-classical members of the family. 
Here we report that the renal expression of MCT14 is regulated by the dietary content 
of phosphate, the generation and validation of a polyclonal antibody to analyze its 
segmental distribution in kidney as well as our attempts to identify substrates. 
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Experimental procedures 
Animals 
All experiments with animals were performed according to Swiss Animal Welfare 
laws and were approved by the local veterinary authority (Veterinäramt Zürich). Male 
mice (C57BL/6) 10 to 13 weeks old were fed for 14 hours or 5 days with either high 
(1.2%) or low (0.1%) phosphate diet (Kliba Promivi AG, Switzerland). Food was 
provided ad libitum and animals had free access to water. After the adaptation, mice 
were anesthetized with a mixture of ketamine and xylazine. Venous blood was 
collected from the vena cava and centrifuged (8 min at 8’000rpm at 4°C) in 
heparinized tubes containing. After centrifugation, the plasma was aliquoted and 
snap frozen in liquid nitrogen. Organs were extracted and snap frozen. All samples 
were stored at -80°C until further use.  
RNA isolation and semi-quantitative real-time PCR (RT-qPCR) 
Snap frozen kidneys were homogenized in RLT buffer (Qiagen, Germany) containing 
1% β-mercaptoethanol. Total RNA was purified from these homogenates using the 
Qiagen RNeasy Mini Kit following the manufacturer’s protocol. Isolated RNA was 
reverse transcribed to cDNA with the TaqMan Reverse Transcription Kit (Applied 
Biosystems), following the manufacturers protocol. 
Specific primers for Slc16a14/MCT14 and Cyp27b1 and the corresponding probe 
labeled with FAM/TAMRA (Mm01272722_m1, Mm01165918_g1; Applied 
Biosystems) as well as for β-actin (Microsynth, Switzerland) were purchased. 
TaqMan universal PCR master mix (Applied Biosystems) containing primers and 
probes in concentrations of 5 μM and 25 μM, respectively, was used to amplify 
cDNA. Relative mRNA expression levels were measured on a 7500 Fast Real Time 
PCR System (Applied Biosystems). The cycle number at a given threshold (Ct) was 
determined, and the relative expression (R) was calculated according to the formula 
R=2^((CT– β-actin) – (CT-MCT14), where R represents the expression of MCT14 
relative to the housekeeping gene (β-actin). 
To analyze the expression of Slc16a14 mRNA in kidneys and oocytes from Xenopus 
laevis, total RNA was prepared and reverse transcribed as indicated above. Then, 
mRNA, was detected by amplification of cDNA with Slc16a14 specific primers 
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(forward: TGC ATG TGT ACT CCA GCC TG, reverse: TGT CAT AGA TCC AAC 
CTG CAA, Microsynth, Switzerland) using TaqMan universal PCR master mix 
(Applied Biosystems), followed by separation on an 1% agarose gel.  
 
Western blot analysis 
Frozen kidneys were homogenized in homogenization buffer (300 mM Mannitol, 5 
mM EGTA, 12 mM Tris/HCl, pH 7.1) for 2 min on ice using a Polytron homogenizer 
(PT 10-35, Kinematica GmbH, Lucerne). The homogenates were then centrifuged for 
5 min at 2’000 rpm at 4°C. Supernatants were collected and protein concentrations 
were determined with the BioRad DC protein assay, based on the Lowry method 
(44). Aliquots of 50 μg of renal homogenates were mixed with Laemmli sample buffer 
(0.38 M Tris base, 8% SDS, 4 mM EDTA, 40% (v/v) glycerol, pH 6.8 with HCl, 4 
mg/ml of Bromphenol Blue) and loaded on a 10 % acrylamide SDS gel for SDS-
PAGE. Proteins were transferred from gel onto polyvinylidene difluoride membranes 
(PVDF; Immobilon-P, Millipore) in a standard tank system (Mini Trans- Blot, Bio-
Rad). PVDF membranes were blocked with TBS containing 5 % fat-free powder milk 
at room temperature and incubated with primary antibodies over night at 4°C. 
Membranes were then washed with TBS and blocked again before incubation with 
secondary antibodies for 2 hours at room temperature. Horseradish peroxidase-
coupled secondary antibodies (GE Healthcare, United Kingdom) were used to detect 
primary antibody binding. Chemiluminescence was detected upon incubation with 
HRP substrate (Western Chemiluminescence HRP Substrate, Millipore) for 5 
minutes, using a LAS-4000 camera system (Fujifilm). 
An antibody targeting a predicted extracellular loop (Uniprot) of MCT14 was raised by 
immunizing rabbits with an antigenic peptide (NH2-
KSGGPLGMAEEQDRRPGNEEMVC-COOH) linked to KLH (Pineda, Berlin, 
Germany). The anti-serum was affinity purified using protein A/G chromatography. 
For deglycosylation of renal proteins the PNGase F kit (New England BioLabs inc., 
Allschwil, Switzerland) was used following the manufacturer’s protocol. Prior to SDS 
page, renal homogenates were treated with PNGase F under denaturing (0.5% SDS 
plus 40 mM DTT, at 95°C and room temperature) and non-denaturing (room 
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temperature) conditions. After incubation for 4 hours with PNGase F, samples were 
mixed with laemmli sample buffer and western blot was performed. 
 
Immunofluorescence 
Animals were perfused through the left cardiac ventricle with a pre-fixative solution 
(1000 U/ml Heparin, 0.2 % procain-HCl, 3.2 % CaCl2 and 0.18 % NaCl) followed by 
the fixative (3 % Paraformaldehyde (PFA)/PBS). After incubation in PFA for one hour, 
kidneys were placed overnight in 32 % sucrose/PBS and subsequently embedded in 
OCT embedding Matrix (Cell Path, Newtown, Wales, United Kingdom) and frozen in 
liquid propane. Cryosections of 5 μm were mounted on slides (Superfrost Plus, 
Thermo Scientific) and blocked with 3 % bovine serum albumin/PBS; the primary 
antibodies against MCT14 (1/1000), NKCC2 [25] (1/1000), Uromodulin [26] (1/400), 
NCC [27] (1/500) or NaPi-IIa [28] (1/400) were diluted in PBS and added to the 
cryosections for incubation over night at 4°C. Then, samples were washed twice with 
hypertonic PBS (18g NaCl/PBS), once with PBS and incubated with the secondary 
antibodies donkey anti-rabbit Alexa 594, donkey anti-sheep Alexa 488 and goat anti-
guinea-pig Alexa 488 (1/1000, Invitrogen) during 2 hours at room temperature. After 
two consecutive washing steps with hypertonic PBS and once with PBS, cover slips 
were mounted with Glycergel (DakoCytomation, Baar, Switzerland). Fluorescence 
was detected with a Leica fluorescence microscope (Leica CTR600). Leica AF lite 
and Image J freeware programs were used to process the pictures. 
Expression of MCT14 in Xenopus laevis oocytes 
An Escherichia coli clone containing the cDNA of murine Slc16a14 inserted into the 
pCMV-Sport6 expression vector downstream of the SP6 promotor 
(IRAVp968E0963D) was purchased from imaGenes (Berlin, Germany). Bacterial 
clones were selected and expanded using standard procedures. The vector was 
purified using the QIAprep Spin Miniprep Kit (QIagen), and was linearized with the 
restriction enzyme NotI. After purification with the QIAquick gel extraction kit 
(Qiagen), the linearized plasmid served as template to synthesize cRNA using the 
mMessage mMachine SP6 kit (Ambion) in the presence of the 5’-cap analogue 
(m7G(5')ppp(5')G (New England BioLabs inc., Allschwil, Switzerland). Upon 
purification, 10 ng of MCT14 cRNA were injected into oocytes isolated from female 
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Xenopus laevis. Three days after cRNA injection, oocytes were used for experiments. 
Non-injected and water-injected oocytes served as control. 
Oocyte preparation for immunodetection of MCT14 
Xenopus laevis oocytes were placed in 20 μl lysis buffer (100 mM NaCl, 20 mM Tris 
HCl (pH 7.6) and 1% Igepal CA 630 (Sigma Aldrich, Buchs, CH)) and lysed by 
pipetting up and down. Lysates were then centrifuged for 3 minutes at 16000g at 
22°C. Yolk-free supernatants were collected avoiding contamination with floating 
lipids and mixed with Laemmli sample buffer. A volume corresponding to 1/3 of an 
oocyte/lane was loaded on an acrylamide SDS gel and protein expression was tested 
following the Western blot protocol described above. 
To prepare Xenopus laevis oocytes for immunohistological detection, cells were 
incubated in 3% PFA in PBS for 4 hours at 4°C. After washing with PBS, oocytes 
were placed in 30 % sucrose/PBS over night at 4°C for cryoprotection. Oocytes were 
then transferred to cryomolds (Cryomold Biopsy, Sakura Finetek Germany GmbH, 
Staufen, Germany) containing embedding medium (OCT embedding Matrix, Cell 
Path, Newtown, Wales, United Kingdom) and were immediately frozen in liquid 
propane. Frozen oocytes were stored at -80°C and processed for 
immunofluorescence experiments as described above. 
Transport studies in Xenopus laevis oocytes expressing MCT14 
Ten oocytes were transferred into plastic vials containing ice cold ND96 (96 mM 
NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM Hepes, pH 7.4 adjusted with 
Tris). ND96 was replaced with ND96 containing 100 μM of the desired uptake 
substrate together with traces of radioactively labelled substrate (5 μCi/ml). Upon 10 
minutes incubation at room temperature, the solution was removed and oocytes were 
subsequently washed 4 times with ice cold ND96. Single oocytes were transferred to 
scintillation vials containing 200 μl of 2% SDS and lysed by shaking. Upon addition of 
Emulsifier-Safe (PerkinElmer), the radioactivity accumulated in each oocyte was 
measured in a -counter (Packard BioScience) and total uptake was calculated. 
Statistical analysis 
Unpaired students t-test was used to compare expression levels. P-values < 0.05 
were considered as significant. Data is presented as Mean + SEM. 
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Results and discussion 
Phosphate plays an essential role in a large variety of vital functions ranging from cell 
signaling and energy metabolism to structural purposes. Hence, it is not surprising 
that changes in phosphate status, as those induced by alterations in dietary 
phosphate intake, have a broader impact on systemic homeostasis than just 
adjusting intestinal and renal (re)absorption of phosphate. Thus, dietary alterations in 
phosphate supply cause a fast response in PTH and later on in vitamin D and FGF23 
[4,5], but also promote changes in other metabolic pathways such as  
gluconeogenesis,  or altered insulin sensitivity [8], indicating the importance of 
phosphate in energy metabolism.  
Dietary phosphate content regulates Slc16a14 mRNA  
A transcriptome analysis using GeneChip Mouse Genome 430 2.0 arrays (Affymetrix, 
Santa Clara, CA) was performed on kidneys from mice adapted to high (1.2 % 
phosphate, HPD) or low (0.1 % phosphate, LPD) dietary phosphate for either 14 
hours or 5 days, conditions that are considered as acute or chronic adaptation, 
respectively. Adaptation to the diets was validated by quantifying the renal protein 
expression of the Na+/phosphate cotransporter NaPi-IIa [29]. As previously reported 
[30], acute (Figure 1A) and chronic (Figure 1B) LPD diets increased the abundance 
of NaPi-IIa protein compared to HPD. The microarray detected more than 12’000 
protein coding transcripts. Only transcripts with at least 1.5 fold change and p-values 
<0.05 were considered for further analysis. Under LPD conditions 50 transcripts were 
found to be upregulated acutely and 1259 under chronic adaptation. LPD further 
decreased the expression of 93 transcripts acutely and 631 chronically (detailed data 
to be reported elsewhere). To validate the data obtained by microarrays, the mRNA 
expression of Cyp27b1 (the 1-alpha-hydroxylase responsible for the last step of 
vitamin D3 activation) was independently quantified by RT-PCR. In agreement with 
previous observations, Cyp27b1 mRNA abundance was not affected by acute 
changes in dietary phosphate (Figure 1C), whereas chronic adaptation to LDP led to 
a 10 fold increase (Figure 1D), confirming that vitamin D3 is not acutely activated by 
phosphate restriction [31]. 
In both, acute and chronic adaptation experiments, transcriptome analysis revealed 
that the mRNA of Slc16a14 (the gene encoding the monocarboxylate transporter 
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MCT14) was strongly regulated. Among the SLC transporter transcripts, SLC16a14 
mRNA appeared to be the most highly affected. In fact Slc16a14 mRNA abundance 
was decreased by a factor of 4.3 in mice acutely fed a LPD as compared with mice 
fed a HPD, whereas the reduction was by a factor of 5.0 in chronically adapted mice. 
The microarray data was confirmed by semi-quantitative real time RT-PCR with renal 
mRNA extracted from the same group of mice as well as from an independent group 
of animals. Already 14 hours after the start of the dietary adaptation renal Slc16a14 
mRNA expression was drastically decreased in animals under LPD condition 
compared with HPD (Figure 1E). This effect was further enhanced after chronic 
adaptation for 5 days (Figure 1F).  
Antibody generation and validation of specificity 
Murine MCT14 consists of 510 amino acids and, as for other members of this family, 
hydropathy plots predict 12 transmembane domains with cytoplasmic N and C-
termini [32]. The predicted topology of MCT1 was experimentally confirmed in 
proteolytic cleavage experiments in red blood cells, where the big intracellular loop 
and the N- and C-termini were only accessible for cleavage in leaky ghosts [33]. To 
investigate if the changes in MCT14 mRNA expression were paralleled by altered 
protein levels, a polyclonal antibody was raised in rabbits against a peptide located in 
a predicted extracellular loop. Western blot analysis with renal homogenates was 
performed in the presence and absence of the antigenic peptide to confirm specific 
binding of the antibody to its epitope (Figure 2A). The anti-MCT14 antibody detected 
one band of about 50 kDa, which is in good agreement with the expected size of the 
full length protein, as well as smaller bands at about 40 kDa that may represent either 
degradation products or unglycosylated proteins, since they were mostly detected in 
boiled samples. A similar pattern of bands was reported in a recent publication using 
a commercial antibody [24]. Preincubation with the antigenic peptide abolished 
detection of both bands but did not affect the binding of the NaPi-IIa [28] antibody in 
the same homogenates (Figure 2B). Further proof of binding specificity was obtained 
by western blots of lysates from Xenopus laevis oocytes injected with 
Slc16a14/MCT14 cRNA or left non-injected. In lysates of oocytes injected with 
Slc16a14/MCT14 cRNA, the antibody detected two bands with molecular sizes of 
about 40 and 50 kDa corresponding to the major bands protected by the antigenic 
peptide in renal homogenates. These bands were absent from non-injected oocytes 
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(Figure 2C). To analyze whether the two bands represent different MCT14 
glycosylated forms, renal protein samples were treated with PNGase F prior to 
Western blotting. These deglycosylation experiments did not show any change in the 
pattern of migration of MCT14 for all the protocols used (Figure 2D), whereas 
deglycosylation treatment of the same sample decreased the size at which NaPi-IIa 
was detected (Figure 2D). Hence the two bands observed are rather unlikely to be 
due to glycosylation. 
Renal localization of MCT14 
Real time PCR on mRNA samples extracted from several mouse tissues indicated 
that the kidney expresses the highest levels of Slc16a14/MCT14 mRNA, followed by 
pancreas and testis where the mRNA expression levels are about ten times lower 
than in kidney (data not shown), confirming a previous report [24]. In 
immunofluorescence experiments on murine kidney cryosections using the newly 
generated MCT14 antibody, staining was observed mainly in the luminal membrane 
of nephron segments located in the outer renal medulla and to a lesser extent in the 
cortex (Figure 2E). Upon co-incubation of the antigenic peptide with the anti-MCT14 
antibody, tubular staining was abolished (figure 2E). These findings indicate specific 
staining of MCT14 in kidney sections using a standard immunofluorescence protocol. 
In order to further characterize the segmental distribution of MCT14 in the murine 
kidney, (co)immunostainings were performed in single or consecutive renal sections 
using the MCT14 antibody as well as antibodies against proteins with well-
established patterns of renal expression. NaPi-IIa, the major Na+-dependent 
phosphate transporter in kidney, was used as a marker for proximal tubules as its 
expression is restricted to the apical membrane of this nephron segment [28]. 
Incubation of consecutive sections with antibodies against MCT14 and NaPi-IIa 
showed that both proteins labelled different nephron segments, with the MCT14 
related signal mostly detected in the outer medulla whereas NaPi-IIa showed the 
expected cortical expression (Figure 3A), thus indicating that MCT14 is not 
expressed in proximal tubule. The NKCC2  cotransporter is expressed in the brush 
border membrane of the thick ascending limb of the loop of Henle (TAL), where it 
mediates the electroneutral reabsorption of 1Na+:1K+.2Cl- [34]. Immunostainings on 
consecutive sections with antibodies against MCT14 and NKCC2 [25] showed that 
both proteins are present in the same cells, in cortex and outer medulla (Figure 3B 
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and 3C). TAL expression of MCT14 was further supported by co-staining of MCT14 
and uromodulin (Tamm-Horsfall protein), a GPI-anchored protein exclusively 
produced by the cells of the TAL and secreted into the urine upon proteolytic 
cleavage [35]. Upon coincubation of renal slices with antibodies against MCT14 and 
uromodulin, all cells positive for MCT14 stained also for uromodulin (Figure 3D). As 
expected, uromodulin staining was present intracellularly as well as on the luminal 
membrane of those cells, whereas MCT14 signal was restricted to the apical 
membrane. In order to investigate if MCT14 is exclusively expressed in the TAL or its 
expression extends into the adjacent distal convoluted tubule (DCT), further co-
stainings were performed with a marker of the DCT, namely the Na+/Cl- cotransporter 
NCC [36]. Coincubation with antibodies against MCT14 and NCC [27] resulted in 
labeling of different tubular segments (Figure 3E), thus confirming that MCT14 is 
located specifically in TAL. 
Dietary phosphate content regulates renal MCT14 protein abundance 
Western blot analysis of renal homogenates from animals used previously for 
transcriptome analysis showed that MCT14 protein abundance followed the 
regulation of mRNA by dietary phosphate. Reduced amounts of MCT14 protein was 
detected after 14 hours and 5 days LPD compared to HPD (Figures 4A and 4B). 
Immunostainings on renal cryosections of mice chronically adapted to HPD and LPD 
did not show a change of expression pattern, with the cortical-medullary gradient 
remaining similar as the one already observed in the initial localization experiments 
(Figure 4C). 
Functional studies in Xenopus laevis oocytes 
To search for transport substrates of MCT14, we used Xenopus oocytes injected 
with/without Slc16a14/MCT14 cRNA. As indicated above, Western blot analysis 
confirmed that the protein was produced by the oocytes (see Figure 2C). Trafficking 
of MCT14 to the membrane of the oocytes was ascertained by immunostaining 
experiments, since proper membrane expression is required for transport studies. 
Oocytes injected with Slc16a14/MCT14 cRNA showed a signal framing the cell body, 
which was absent from non-expressing cells (Figure 2F), indicating insertion of 
MCT14 into the oocyte cell membrane. 
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Oocytes expressing MCT14 and non-injected oocytes were incubated with several 
substrates previously shown to be transported by different members of the MCT 
family. The physiological role of the classical monocarboxylate transporters MCT1-4 
is the import and export of lactate as a substrate of oxidation or end product of 
glycolysis. MCT1, 3 and 4 interact with the accessory protein CD147 and for MCT1 it 
is well documented that association with CD147 is required for proper targeting to the 
basolateral membrane of the proximal tubule [11]. However, oocytes injected with 
Slc16a14/MCT14 mRNA did not show any significant transport activity for lactate 
compared to non-injected oocytes, neither at substrate concentrations of 3 mM 
(Figure 5A) or at 100 μM (Table 1). Coexpression of MCT14 with CD147 also failed 
to induce lactate transport. Previous experiments detected CD147 at the basolateral 
membrane of TAL cells [12] whereas MCT14 appears to be restricted to the apical 
membrane of these cells making a potential direct interaction between these two 
proteins in vivo rather unlikely. Phylogenetically MCT14 is closer related to MCT8 
and MCT10, than to the classical monocarboxylate transporters. MCT8 and MCT10 
transport thyroid hormone [14] and aromatic amino acids [16] respectively. A recent 
study suggested that MCT14 might be involved in transport of amino acids, rather  
than in the shuttling of monocarboxylates [24].  Therefore, further uptake experiments 
were performed in which oocytes were incubated with different amino acids (alanine, 
glutamine, cysteine, asparagine, serine, methionine, tyrosine and glutamate) in 100 
μM concentrations. No significant differences were observed comparing oocytes 
expressing MCT14 and the corresponding non-expressing cells, except for a 
tendency of slightly higher import of serine and glutamate, which could be due to 
structural homologies to endogenous substrate (Figure 5C, Table 1). Similarly, 
MCT14 failed to induce transport of tryptophan, phenylalanine, valine, leucine and 
isoleucine, with substrates present at 3 mM concentrations (Table 1). However, the 
rate of induction was very small and may represent rather the stimulation of an 
endogenous Xenopus transport system than transport by MCT14 itself. Since most 
amino acids are already absorbed in the proximal tubule, very low concentrations are 
reaching the TAL; therefore, amino acid transporters located in the TAL would be 
expected to have rather the properties of a high affinity transporter. Another member 
of the MCT family, which has been recently characterized, is MCT12. MCT12 has 
been shown to be a creatine transporter [17]. However, creatine was not transported 
either by oocytes injected with MCT14, whereas this substrate was incorporated by 
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MCT12 expressing oocytes (Figure 5B).  Introduction of CD147 had again no effect in 
Slc16a14/MCT14 expressing oocytes regarding their failure to transport creatine. 
Similarly, inorganic phosphate was not accumulated in oocytes expressing MCT14 
(Table 1). Of interest, Ansermet et al just reported a renal Xpr1 knock out mouse 
model, which develops hypophosphatemic rickets, and in which Slc16a14 mRNA was 
strongly suppressed [37], similar to our observations under low dietary phosphate 
content . Xpr1 is a protein thought to be involved in phosphate export [38], though its 
direct function remains to be proven. Although we failed to show phosphate transport 
activity, MCT14 might be involved in the metabolic adaptation to alterations in 
phosphate homeostasis. No endogenous Slc16a14 mRNA was detected in Xenopus 
laevis oocytes, whereas the same amount of mRNA from Xenopus laevis kidney 
resulted in a strong band of expected size (Figure 5D). This indicates that MCT14 is 
also expressed in kidney of Xenopus laevis but not in oocytes, where it could 
interfere with transport studies. 
In summary, we showed that the renal abundance of MCT14 is highly regulated by 
the dietary content of phosphate and that its expression in kidney is restricted to the 
luminal side of the TAL.  However, MCT14 seems to transport neither phosphate nor 
several other substrates of different members of the MCT family. 
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Figure legend 
Figure 1: Renal adaptation to low (LPD) and high (HPD) dietary phosphate. 
Adaptation was confirmed by the expression of NaPi-IIa protein abundance in 
kidneys of mice fed 14 hours (A) and 5 days (B) with both diets. β-actin was used as 
a loading control. Renal mRNA expression of Cyp27b1 and MCT14 after either 14 
hours (C and E) or 5 days (D and F) of LPD respectively HPD, n = 5-6 animals/group.  
Statistical differences were calculated with t-test: *p<0.05, **p<0.01 and ***p<0.001. 
Figure 2:  Validation of a newly generated MCT14 antibody. Renal homogenates 
were incubated with antibodies against MCT14 (A) and NaPi-IIa (B) in the presence 
and absence of the antigenic peptide as indicated. Lysates of Xenopus laevis 
oocytes injected with MCT14 cRNA and non-injected oocytes (n.i.) were incubated 
with the MCT14 antibody (C); renal homogenate was loaded in the last lane (+). 
Deglycosylated (+ PNGase) and native (- PNGase) renal homogenates were 
incubated with antibodies against MCT14 and NaPi-IIa (D).   Immunofluorescence 
was performed on kidney cryosections in the presence and absence of the antigenic 
peptide (E). Immunofluorescence in oocytes expressing MCT14 and corresponding 
non-injected oocytes (F). 
Figure 3: MCT14 renal localization. Consecutive sections showing MCT14 and NaPi-
IIa localization (A). Cortical (B) and outer medullary (C) staining patterns of MCT14 
and NKCC2 on consecutive sections. Costainings performed with MCT14 and 
uromodulin (D) or NCC (E) on renal sections. MCT14 is shown in red, NaPi-IIa, 
NKCC2, uromodulin and NCC are represented in green and blue indicates nuclear 
fluorescence (DAPI). 
Figure 4: Regulation of MCT14 protein abundance by dietary phosphate. Western 
blotting with MCT14 antibody was performed on renal homogenates from animals fed 
14 hours (A) and 5 days (B) with either low (LPD) or high (HPD) phosphate. 
Expression levels were normalized to corresponding β-actin levels. MCT14 protein 
abundance was significantly increased in animals fed a HPD compared to LPD as 
indicated in the corresponding densitometric analysis. Statistical differences were 
calculated with t-test: *p<0.05 and ***p<0.001. Immunofluorescence staining against 
MCT14 was performed in kidneys of mice fed HPD or LPD for 5 days (C). 
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Figure 5: Uptake in X. laevis oocytes. Lactate transport was assessed in Xenopus 
laevis oocytes injected with cRNA of MCT14 and CD147, in oocytes injected with 
MCT14 or CD147 alone and non-injected oocytes (NI) (A). Oocytes expressing 
MCT12 and CD147, MCT14, MCT14 and CD147 and non-expressing oocytes (N.I.) 
were used to perform creatine uptake (B). Transport of the indicated amino acids into 
oocytes expressing MCT14 is given in relation of uptakes into non-injected oocytes 
(NI) (C). Slc16a14 mRNA was detected in Xenopus laevis kidney but not oocytes (D). 
Each experiment was performed with at least n = 7-10 oocytes. 
 
Table 1: Transport studies in Xenopus laevis oocytes [pmol/10min] 
Substrate MCT14 Non injected 
  
Lactate 7.593 ± 0.600 7.174 ± 1.620  
Pyruvate 0.300 ± 0.063 1.177 ± 0.169 * 
Alanine 4.430 ± 0.702 5.135 ± 2.803  
Methionine 4.784 ± 0.906 4.863 ± 1.789  
Cysteine 0.635 ± 0.177 0.489 ± 0.076  
Cystine 6.601 ± 1.419 7.866 ± 0.962  
Glutamine 2.676 ± 0.274 6.053 ± 2.502 * 
Serine 12.29 ± 7.19 7.52 ± 4.49  
Tyrosine 11.44 ± 1.05 12.69 ± 1.32  
Glutamate 0.882 ± 0.685 0.628 ± 0.278  
Aspartate 1.770 ± 0.327 1.625 ± 0.176  
Isoleucine 4.955 ± 6.238 1.997 ± 2.152  
Valine 25.70 ± 1.97 24.70 ± 3.23  
Tryptophane 90.97 ± 14.58 100.93 ± 8.41  
Phenylalanine 81.18 ± 23.12 86.28 ± 15.39  
Phosphate 1.384 ± 0.479 1.376 ± 0.377  
Urate 0.0039 ± 0.0015 0.0087 ± 0.0039 * 
Citrate 6.442 ± 3.022 5.452 ± 0.462  
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